MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,575,880 | -33.1% | 13,626,925 | -3.4% | 0.01% | -33.3% |
| Q2 2023 | $326,944,722 | -0.4% | 14,104,604 | -0.2% | 0.01% | -10.0% |
| Q1 2023 | $328,186,658 | +57.5% | 14,127,708 | -1.6% | 0.01% | +42.9% |
| Q4 2022 | $208,306,995 | -25.1% | 14,356,099 | -1.6% | 0.01% | -22.2% |
| Q3 2022 | $278,248,000 | +3.8% | 14,583,195 | -1.2% | 0.01% | 0.0% |
| Q2 2022 | $268,160,000 | -28.1% | 14,758,400 | -0.3% | 0.01% | -10.0% |
| Q1 2022 | $372,906,000 | -8.0% | 14,797,829 | +0.8% | 0.01% | 0.0% |
| Q4 2021 | $405,301,000 | -7.4% | 14,684,787 | +8.3% | 0.01% | -16.7% |
| Q3 2021 | $437,896,000 | +5.3% | 13,561,305 | -0.3% | 0.01% | 0.0% |
| Q2 2021 | $416,000,000 | +3.3% | 13,603,670 | +2.8% | 0.01% | 0.0% |
| Q1 2021 | $402,850,000 | +62.9% | 13,229,879 | +5.8% | 0.01% | +50.0% |
| Q4 2020 | $247,226,000 | +52.7% | 12,501,920 | +0.7% | 0.01% | +33.3% |
| Q3 2020 | $161,859,000 | +13.0% | 12,412,434 | -1.7% | 0.01% | 0.0% |
| Q2 2020 | $143,253,000 | -19.6% | 12,632,423 | +1.4% | 0.01% | -33.3% |
| Q1 2020 | $178,285,000 | -48.7% | 12,458,686 | -2.3% | 0.01% | -30.8% |
| Q4 2019 | $347,242,000 | -2.8% | 12,752,119 | +2.2% | 0.01% | -13.3% |
| Q3 2019 | $357,172,000 | +2.6% | 12,475,380 | -0.5% | 0.02% | 0.0% |
| Q2 2019 | $348,233,000 | -12.8% | 12,535,346 | +4.2% | 0.02% | -16.7% |
| Q1 2019 | $399,268,000 | +12.6% | 12,026,132 | -1.4% | 0.02% | 0.0% |
| Q4 2018 | $354,727,000 | -32.7% | 12,202,442 | +6.4% | 0.02% | -21.7% |
| Q3 2018 | $527,464,000 | +27.3% | 11,466,610 | +3.5% | 0.02% | +21.1% |
| Q2 2018 | $414,192,000 | +34.9% | 11,083,521 | +6.7% | 0.02% | +26.7% |
| Q1 2018 | $307,091,000 | -11.2% | 10,392,278 | +3.2% | 0.02% | -6.2% |
| Q4 2017 | $345,743,000 | -3.6% | 10,066,753 | +1.5% | 0.02% | -11.1% |
| Q3 2017 | $358,788,000 | +46.9% | 9,916,750 | +4.9% | 0.02% | +38.5% |
| Q2 2017 | $244,174,000 | +33.3% | 9,449,527 | -1.0% | 0.01% | +30.0% |
| Q1 2017 | $183,203,000 | +194796.8% | 9,541,884 | +168335.7% | 0.01% | – |
| Q4 2016 | $94,000 | -72.2% | 5,665 | -65.5% | 0.00% | – |
| Q3 2016 | $338,000 | -37.3% | 16,415 | -7.0% | 0.00% | -100.0% |
| Q2 2016 | $539,000 | +206.2% | 17,647 | +274.3% | 0.00% | – |
| Q1 2016 | $176,000 | +93.4% | 4,715 | +123.4% | 0.00% | – |
| Q4 2015 | $91,000 | +24.7% | 2,111 | +8.4% | 0.00% | – |
| Q3 2015 | $73,000 | +10.6% | 1,947 | +1.5% | 0.00% | – |
| Q2 2015 | $66,000 | -9.6% | 1,919 | -7.3% | 0.00% | – |
| Q1 2015 | $73,000 | +2.8% | 2,070 | 0.0% | 0.00% | – |
| Q4 2014 | $71,000 | -14.5% | 2,070 | -4.5% | 0.00% | – |
| Q3 2014 | $83,000 | -67.5% | 2,168 | -66.9% | 0.00% | – |
| Q2 2014 | $255,000 | +30.1% | 6,545 | +13.8% | 0.00% | – |
| Q1 2014 | $196,000 | -14.8% | 5,751 | -47.5% | 0.00% | – |
| Q4 2013 | $230,000 | +90.1% | 10,953 | +113.4% | 0.00% | – |
| Q3 2013 | $121,000 | -83.4% | 5,132 | -81.1% | 0.00% | -100.0% |
| Q2 2013 | $730,000 | – | 27,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |